Modified ASRA facilitates the characterization of activating point mutations in tumors, in which cancer cells constitute only a minor part of the investigated tissue.
Papp
T
T
Institute of Toxicology, University of Würzburg, Germany.
Jafari
M
M
Diener
U
U
Dudley
N
N
Schiffmann
D
D
D001483:Base Sequence; D017931:DNA Primers; D015972:Gene Expression Regulation, Neoplastic; D011905:Genes, ras; D006801:Humans; D007202:Indicators and Reagents; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000235:genetics*; D016376:Oligonucleotides, Antisense; D017354:Point Mutation; D016133:Polymerase Chain Reaction / Q000379:methods*
D017931:DNA Primers; D007202:Indicators and Reagents; D016376:Oligonucleotides, Antisense